KG&L Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,751
| Closed | -$240K | – | 189 |
|
|
2024
Q1 | $240K | Sell |
1,751
-105
| -6% | -$14.4K | 0.1% | 160 |
|
|
2023
Q4 | $252K | Sell |
1,856
-254
| -12% | -$34.5K | 0.11% | 148 |
|
|
2023
Q3 | $258K | Sell |
2,110
-236
| -10% | -$28.9K | 0.12% | 131 |
|
|
2023
Q2 | $298K | Sell |
2,346
-245
| -9% | -$31.1K | 0.14% | 120 |
|
|
2023
Q1 | $335K | Buy |
2,591
+4
| +0.2% | +$517 | 0.18% | 97 |
|
|
2022
Q4 | $340K | Sell |
2,587
-34
| -1% | -$4.47K | 0.2% | 94 |
|
|
2022
Q3 | $307K | Sell |
2,621
-182
| -6% | -$21.3K | 0.17% | 96 |
|
|
2022
Q2 | $330K | Sell |
2,803
-43
| -2% | -$5.06K | 0.18% | 93 |
|
|
2022
Q1 | $371K | Buy |
2,846
+506
| +22% | +$66K | 0.15% | 105 |
|
|
2021
Q4 | $357K | Buy |
+2,340
| New | +$357K | 0.14% | 110 |
|
|
2021
Q3 | – | Sell |
-3,781
| Closed | -$619K | – | 141 |
|
|
2021
Q2 | $619K | Buy |
+3,781
| New | +$619K | 0.28% | 82 |
|
|
2019
Q4 | – | Sell |
-2,218
| Closed | -$220K | – | 93 |
|
|
2019
Q3 | $220K | Buy |
+2,218
| New | +$220K | 0.2% | 87 |
|
|
2019
Q1 | – | Sell |
-4,949
| Closed | -$479K | – | 85 |
|
|
2018
Q4 | $479K | Buy |
+4,949
| New | +$479K | 0.54% | 53 |
|